Cargando…
Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments
Schizophrenia is a major mental illness characterized by positive and negative symptoms, and by cognitive deficit. Although cognitive impairment is disabling for patients, it has been largely neglected in the treatment of schizophrenia. There are several reasons for this lack of treatments for cogni...
Autores principales: | Martínez, Antón L., Brea, José, Rico, Sara, de los Frailes, María Teresa, Loza, María Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468549/ https://www.ncbi.nlm.nih.gov/pubmed/34576069 http://dx.doi.org/10.3390/ijms22189905 |
Ejemplares similares
-
Development of a novel in vitro assay to screen for neuroprotective drugs against iatrogenic neurite shortening
por: Martínez, Antón L., et al.
Publicado: (2021) -
S62. COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Millgate, Edward, et al.
Publicado: (2020) -
Cognitive deficits in familial schizophrenia
por: Saha, Aneek, et al.
Publicado: (2021) -
Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence
por: Fioravanti, Mario, et al.
Publicado: (2012) -
2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306),
an Orally Bioavailable Positive Allosteric Modulator of the Human
Dopamine D(1) Receptor for Parkinson’s Disease
por: García-Cárceles, Javier, et al.
Publicado: (2022)